{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:59:12Z","timestamp":1788238752330,"version":"build-2803163510"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Differentiation of an adrenal from an ovarian source of hyperandrogenemia can be challenging. Recent studies have highlighted the importance of 11-oxygenated C19 steroids to the androgen pool in humans. The aim of this study was to confirm the origin of 11-oxygenated androgens in females and to explore their potential use in the diagnostics of hyperandrogenic disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We measured testosterone and its precursors (dehydroepiandrosterone-sulfate and androstenedione) and 11-oxygenated androgens (11\u03b2-hydroxyandrostenedione (11-OHA4) and 11-ketotestosterone (11-KT)) in the periphery, adrenal and ovarian veins in four different cases of hyperandrogenism in females (polycystic ovary syndrome (PCOS), primary bilateral macronodular adrenal hyperplasia, Sertoli\u2013Leydig cell tumor and ovarian steroid cell tumor).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Two patients demonstrate excessive testosterone secretion in neoplastic ovarian tumors which was not paralleled by a significant secretion of 11-oxygenated androgens as determined by adrenal and ovarian vein sampling. In androgen-secreting bilateral adrenal macronodular hyperplasia, steroid profiles were characterized by elevated 11-KT and 11-OHA4 concentrations in adrenal veins and the periphery. In the patient with PCOS, peripheral 11-KT concentrations were slightly elevated in comparison to the other patients, but the 11-KT and 11-OHA4 concentrations were comparable in ovarian veins and in the periphery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study confirms that 11-OHA4 and 11-KT are not biosynthesized by the ovary. We propose that the testosterone\/11-KT ratio as well as 11-OHA4 could help identify predominant adrenal androgen excess and distinguish neoplastic and non-neoplastic ovarian androgen source.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance statement<\/jats:title>\n                    <jats:p>This study confirms that 11\u03b2-hydroxyandrostenedione (11-OHA4) and 11-ketotestosterone (11-KT) are not biosynthesized by the human ovary. We propose that the testosterone\/11-KT ratio as well as 11-OHA4 could help to identify predominant adrenal androgen excess and distinguish neoplastic and non-neoplastic ovarian androgen source.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/eje-22-0518","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T11:17:07Z","timestamp":1665746227000},"page":"K47-K53","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-7","source":"Crossref","is-referenced-by-count":13,"title":["11-Oxygenated androgens are not secreted by the human ovary:\n                    <i>in-vivo<\/i>\n                    data from four different cases of hyperandrogenism"],"prefix":"10.1093","volume":"187","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7153-8332","authenticated-orcid":false,"given":"Matthias K","family":"Auer","sequence":"first","affiliation":[{"name":"Medizinische Klinik and Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen , Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M","family":"Hawley","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Manchester University Foundation NHS Trust, Manchester Academic Health Sciences Centre , Southmoor Rd, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lottspeich","sequence":"additional","affiliation":[{"name":"Medizinische Klinik and Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen , Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bidlingmaier","sequence":"additional","affiliation":[{"name":"Medizinische Klinik and Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen , Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Sappl","sequence":"additional","affiliation":[{"name":"Medizinische Klinik and Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen , Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3791-9929","authenticated-orcid":false,"given":"Hanna F","family":"Nowotny","sequence":"additional","affiliation":[{"name":"Medizinische Klinik and Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen , Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Tschaidse","sequence":"additional","affiliation":[{"name":"Medizinische Klinik and Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen , Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Treitl","sequence":"additional","affiliation":[{"name":"Department for Radiology, Neuroradiology and Interventional Radiology, Trauma Centre Murnau , Germany"},{"name":"Clinic and Polyclinic for Radiology, Clinical Centre of the University of Munich, LMU Munich , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9817-9875","authenticated-orcid":false,"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[{"name":"Medizinische Klinik and Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen , Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G","family":"Keevil","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Manchester University Foundation NHS Trust, Manchester Academic Health Sciences Centre , Southmoor Rd, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7469-6069","authenticated-orcid":false,"given":"Nicole","family":"Reisch","sequence":"additional","affiliation":[{"name":"Medizinische Klinik and Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, LMU M\u00fcnchen , Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,11,23]]},"reference":[{"key":"2023012409095603800_bib1","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/humrep\/des028","article-title":"Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors","volume":"27","author":"Sanch\u00f3n","year":"2012","journal-title":"Human Reproduction"},{"key":"2023012409095603800_bib2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocrine Reviews"},{"key":"2023012409095603800_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2005-1457","article-title":"Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism","volume":"91","author":"Carmina","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023012409095603800_bib4","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1210\/jc.2002-020922","article-title":"The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women","volume":"88","author":"Kaltsas","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023012409095603800_bib5","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/BF03343904","article-title":"Testosterone-secreting gonadotropin-responsive adrenal adenoma and its treatment with the antiandrogen flutamide","volume":"24","author":"L\u00e1szl\u00f3","year":"2001","journal-title":"Journal of Endocrinological Investigation"},{"key":"2023012409095603800_bib6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2265.1994.tb01820.x","article-title":"Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing turnours","volume":"41","author":"Pascale","year":"1994","journal-title":"Clinical Endocrinology"},{"key":"2023012409095603800_bib7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/eje.0.1420619","article-title":"Use of a long-acting gonadotrophin-releasing hormone analogue in a postmenopausal woman with hyperandrogenism due to a hilus cell tumour","volume":"142","author":"Pic\u00f3n","year":"2000","journal-title":"European Journal of Endocrinology"},{"key":"2023012409095603800_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mce.2010.05.012","article-title":"Human adrenal LH\/hCG receptors and what they could mean for adrenal physiology and pathology","volume":"329","author":"Rao","year":"2010","journal-title":"Molecular and Cellular Endocrinology"},{"key":"2023012409095603800_bib9","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJM199410133311502","article-title":"Identification of virilizing adrenal tumors in hirsute women","volume":"331","author":"Derksen","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"2023012409095603800_bib10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/RLU.0b013e3181cc6467","article-title":"F-18 FDG PET\/CT imaging of a Leydig cell tumor","volume":"35","author":"Lee","year":"2010","journal-title":"Clinical Nuclear Medicine"},{"key":"2023012409095603800_bib11","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1210\/jc.2018-00241","article-title":"Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society* clinical practice guideline","volume":"103","author":"Martin","year":"2018","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023012409095603800_bib12","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1210\/jc.2012-2912","article-title":"Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation","volume":"98","author":"Rege","year":"2013","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023012409095603800_bib13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/EJE-15-1181","article-title":"Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency","volume":"174","author":"Turcu","year":"2016","journal-title":"European Journal of Endocrinology"},{"key":"2023012409095603800_bib14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1530\/EJE-22-0320","article-title":"oxygenated C19 steroids are the predominant androgens responsible for hyperandrogenemia in Cushing's disease","volume":"187","author":"Nowotny","year":"2022","journal-title":"European Journal of Endocrinology"},{"key":"2023012409095603800_bib15","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1210\/jc.2016-2311","article-title":"11-ketotestosterone is a major androgen produced in human gonads","volume":"101","author":"Imamichi","year":"2016","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023012409095603800_bib16","first-page":"1","article-title":"Auchus RJ & Rainey WE. 11-Oxygenated androgens in health and disease","author":"Turcu","year":"2020","journal-title":"Nature Reviews Endocrinology"},{"key":"2023012409095603800_bib17","first-page":"4589","article-title":"11-Ketotestosterone is the dominant circulating bioactive androgen during normal and premature adrenarche","volume":"103","author":"Rege","year":"2018","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023012409095603800_bib18","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1159\/000513236","article-title":"The unique role of 11-oxygenated C19 steroids in both premature adrenarche and premature pubarche","volume":"93","author":"Wise-Oringer","year":"2020","journal-title":"Hormone Research in Paediatrics"},{"key":"2023012409095603800_bib19","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1507\/endocrj.EJ18-0212","article-title":"11-oxygenated C19 steroids as circulating androgens in women with polycystic ovary syndrome","volume":"65","author":"Yoshida","year":"2018","journal-title":"Endocrine Journal"},{"key":"2023012409095603800_bib20","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jc.2016-3285","article-title":"11-oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome","volume":"102","author":"O'Reilly","year":"2017","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023012409095603800_bib21","doi-asserted-by":"crossref","first-page":"bvac037","DOI":"10.1210\/jendso\/bvac037","article-title":"11-Oxyandrogens in adolescents With polycystic ovary syndrome","volume":"6","author":"Taylor","year":"2022","journal-title":"Journal of the Endocrine Society"},{"key":"2023012409095603800_bib22","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1515\/cclm-2019-0959","article-title":"Development of a total serum testosterone, androstenedione, 17-hydroxyprogesterone, 11\u03b2-hydroxyandrostenedione and 11-ketotestosterone LC-MS\/MS assay and its application to evaluate pre-analytical sample stability","volume":"58","author":"Hawley","year":"2020","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"key":"2023012409095603800_bib23","doi-asserted-by":"crossref","first-page":"E518","DOI":"10.1210\/jc.2013-3198","article-title":"Transcriptome profiling reveals differentially expressed transcripts between the human adrenal zona fasciculata and zona reticularis","volume":"99","author":"Rege","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023012409095603800_bib24","doi-asserted-by":"crossref","first-page":"730947","DOI":"10.3389\/fendo.2021.730947","article-title":"Morphologic and molecular characterization of adrenals and adrenal rest affected by congenital adrenal hyperplasia","volume":"12","author":"Kolli","year":"2021","journal-title":"Frontiers in Endocrinology (Lausanne)"},{"key":"2023012409095603800_bib25","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1210\/clinem\/dgab598","article-title":"Production of 11-oxygenated androgens by testicular adrenal rest tumors","volume":"107","author":"Schr\u00f6der","year":"2022","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2023012409095603800_bib26","doi-asserted-by":"crossref","first-page":"bqac068","DOI":"10.1210\/endocr\/bqac068","article-title":"Conversion of classical and 11-oxygenated androgens by insulin-induced AKR1C3 in a model of human PCOS adipocytes","volume":"163","author":"Paulukinas","year":"2022","journal-title":"Endocrinology"},{"key":"2023012409095603800_bib27","doi-asserted-by":"crossref","first-page":"bvac037","DOI":"10.1210\/jendso\/bvac037","article-title":"11-Oxyandrogens in adolescents With polycystic ovary syndrome","volume":"6","author":"Taylor","year":"2022","journal-title":"Journal of the Endocrine Society"},{"key":"2023012409095603800_bib28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11154-007-9054-0","article-title":"The adrenal and polycystic ovary syndrome","volume":"8","author":"Yildiz","year":"2007","journal-title":"Reviews in Endocrine and Metabolic Disorders"},{"key":"2023012409095603800_bib29","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.fertnstert.2016.06.039","article-title":"Androgen responses to adrenocorticotropic hormone infusion among individual women with polycystic ovary syndrome","volume":"106","author":"Maas","year":"2016","journal-title":"Fertility and Sterility"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/187\/6\/EJE-22-0518.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eje.bioscientifica.com\/downloadpdf\/journals\/eje\/187\/6\/EJE-22-0518.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/187\/6\/K47\/48837690\/eje-22-0518.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/187\/6\/K47\/48837690\/eje-22-0518.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:18:17Z","timestamp":1676373497000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/187\/6\/K47\/6979888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,23]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.1530\/eje-22-0518","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12]]},"published":{"date-parts":[[2022,11,23]]}}}